Macquarie Group
MYOV

Macquarie Group’s Myovant Sciences Ltd. MYOV Stock Holding History

Macquarie Group’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,502
Closed -$50K – 2216
2022
Q3 		$50K Sell
2,502
-256
-9% -$4.09K ﹤0.01% 1958
2022
Q2 		$34K Hold
2,758
– – ﹤0.01% 2157
2022
Q1 		$37 Hold
2,758
– – ﹤0.01% 2246
2021
Q4 		$43K Sell
2,758
-1,730
-39% -$33K ﹤0.01% 2208
2021
Q3 		$101K Buy
4,488
+2,502
+126% +$54.9K ﹤0.01% 1983
2021
Q2 		$45K Buy
1,986
+1,293
+187% +$27.2K ﹤0.01% 2181
2021
Q1 		$14K Buy
+693
New +$15.8K ﹤0.01% 2352
2020
Q4 		– Sell
-1,021
Closed -$14K – 2387
2020
Q3 		$14K Hold
1,021
– – ﹤0.01% 2234
2020
Q2 		$21K Buy
+1,021
New +$13.9K ﹤0.01% 2157
2019
Q1 		– Sell
-175
Closed -$3K – 2151
2018
Q4 		$3K Sell
175
-25
-13% -$493 ﹤0.01% 2171
2018
Q3 		$5K Buy
+200
New +$4.53K ﹤0.01% 2073
2018
Q1 		– Sell
-600
Closed -$8K – 2438
2017
Q4 		$8K Buy
+600
New +$8.04K ﹤0.01% 2321

Other funds holding MYOV

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Macquarie Group's MYOV Position: Q4 2022 in Review

Macquarie Group sold out of Myovant Sciences Ltd. (MYOV) in Q4 2022, closing a stake of 2,502 shares — an estimated $50K sold.

Macquarie Group first reported a position in MYOV in Q4 2017 and held it in 12 quarters. The position peaked at $101K in Q3 2021. 118 funds tracked by Wall St. Rank hold MYOV as of Q4 2022.

  • Macquarie Group reported no remaining Myovant Sciences Ltd. position as of Q4 2022 after selling out during the quarter.
  • Macquarie Group sold 2,502 Myovant Sciences Ltd. shares in Q4 2022, an estimated $50K.
  • Macquarie Group first reported a position in Myovant Sciences Ltd. in Q4 2017 and held it in 12 quarters.
  • Macquarie Group's Myovant Sciences Ltd. position peaked at $101K in Q3 2021.
  • 118 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2022.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.